甲型玻尿酸毒素是一种潜在的治疗药物,用于慢性口腔面部疼痛
Yu-Mi Kim1, Jo-Young Son1, Dong-Kuk Ahn1
1Department of Oral Physiology, School of Dentistry, Kyungpook National University, Daegu, South Korea.
Journal of oral biosciences
|June 22, 2024
概括
毒素A型 (BTX-A) 在其他治疗方法失败时,为神经病痛和三角神经疼痛等慢性疾病提供有效的疼痛缓解. 这篇评论探讨了BTX-A.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 疼痛管理 疼痛管理
背景情况:
- 毒素A型 (BTX-A) 是来自Clostridium botulinum的衍生物,通过裂解SNAP-25来起作用,这对神经递质释放至关重要.
- BTX-A在治疗慢性疼痛方面表现出有效性,包括腰部疼痛,部疼痛,神经病变性疼痛和三角神经疼痛,特别是在抗常规止痛药的病例中.
- 本综述专门研究了BTX-A在口面区域内的止痛特性.
研究的目的:
- 审查BTX-A诱导的炎症和关节疼痛疼痛的机制.
- 突出BTX-A在管理难以治疗的神经病痛和三角神经疼痛方面的有效性.
- 提供BTX-A的中央止痛作用及其在临床牙科实践中的应用的全面评估.
主要方法:
- 文献综述侧重于研究BTX-A.的止痛作用的研究.
- 关于BTX-A在疼痛调节中的作用机制的证据分析.
- 讨论慢性疼痛管理中的临床应用和患者结果.
主要成果:
- 在各种慢性疼痛条件下,BTX-A显示出显著的止痛作用.
- 证据支持BTX-A在治疗口腔面部疼痛,包括炎症和关节疼痛方面的有效性.
- BTX-A对神经病痛和对传统治疗无反应的三角神经疼痛是有效的.
结论:
- BTX-A是慢性疼痛管理的批准和有前途的治疗选择.
- 虽然注意到轴突运输,但BTX-A的精确疼痛调节机制需要进一步阐明.
- 对于慢性疼痛患者,BTX-A提供了一种有价值的替代方案,这些患者的慢性疼痛条件不耐常规止痛药,特别是在口腔和面部区域.
相关概念视频
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
672
Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...
The binding of dantrolene to the RYR1...
672
Skeletal Muscle Relaxants: Therapeutic Uses
480
Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...
480
Centrally Acting Muscle Relaxants: Therapeutic Uses
666
Centrally acting muscle relaxants reduce muscle tone and tension by interfering with the postsynaptic reflexes in the central nervous system.
Centrally acting drugs are classified into spasmolytic and antispasmodic drugs. Spasmolytic drugs such as baclofen, diazepam, and tizanidine inhibit spinal motor neurons and decrease muscle tone. Spasmolytic drugs are administered for severe and chronic spasms due to multiple sclerosis, cerebral palsy, stroke, and spinal cord and muscle injuries. However,...
Centrally acting drugs are classified into spasmolytic and antispasmodic drugs. Spasmolytic drugs such as baclofen, diazepam, and tizanidine inhibit spinal motor neurons and decrease muscle tone. Spasmolytic drugs are administered for severe and chronic spasms due to multiple sclerosis, cerebral palsy, stroke, and spinal cord and muscle injuries. However,...
666
Peripherally and Centrally Acting Muscle Relaxants: A Comparison
3.3K
Skeletal muscle relaxants can target the central nervous system [CNS] to reduce muscle tension or act directly at the neuromuscular junction to induce temporary paralysis. These two classes of muscle relaxants are called centrally acting muscle relaxants and peripherally acting muscle relaxants. They differ in their action, mechanism, administration route, and clinical uses.
Centrally acting muscle relaxants can be further divided into spasmolytic and antispasmodic drugs. Spasmolytic...
Centrally acting muscle relaxants can be further divided into spasmolytic and antispasmodic drugs. Spasmolytic...
3.3K
Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions
409
Nondepolarizing neuromuscular blockers prevent the membrane depolarization of muscle cells and inhibit muscle contraction. These are usually administered with anesthetics to achieve complete muscle relaxation. Upon administration, these drugs first block the small, rapidly contracting muscles of the face and hands, followed by the larger muscles of the trunk and the intercostal muscles. The diaphragm is the last muscle to be affected.
Although all competitive neuromuscular blockers are designed...
Although all competitive neuromuscular blockers are designed...
409
Analgesia and Pain Management
575
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
575


